Impact of laughter therapy on depression and fatigue
Not Applicable
- Conditions
- Patients with End Stage Renal Disease ( ESRD) under hemodialysis.Chronic kidney disease, stage 5
- Registration Number
- IRCT20180329039157N1
- Lead Sponsor
- niversity of social welfare and rehabilitation sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Patients with renal failure undergoing hemodialysis.
Having a visual and auditory ability and satisfaction to participate in the study.
Have at least 18 years of age to enter the study.
Exclusion Criteria
The questionnaire should not be filled completely by the subject.
The subject leaves the study during the research.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression score in Beck's questionnaire. Timepoint: Measure the patient's depression score before intervention and then at the end of the last intervention session. Method of measurement: Beck Depression Inventory 2.;Fatigue score in multi-dimensional fatigue inventory (MFI). Timepoint: Measure the fatigue score before the intervention and then at the end of the last intervention session. Method of measurement: multidimensional fatigue inventory (MFI).
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie laughter therapy's effects on depression and fatigue in ESRD patients?
How does laughter therapy compare to standard-of-care interventions for managing depression and fatigue in hemodialysis patients?
Are there specific biomarkers that predict response to laughter therapy in ESRD patients undergoing hemodialysis?
What are the potential adverse events associated with laughter therapy in patients with chronic kidney disease stage 5?
What combination approaches or alternative therapies show promise alongside laughter therapy for ESRD-related depression and fatigue?